Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History GLSI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics GLSI

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Greenwich Lifesciences Inc

GLSI
Current price
8.76 USD -0.17 USD (-1.90%)
Last closed 8.90 USD
ISIN US3968791083
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 119 245 240 USD
Yield for 12 month -43.48 %
1Y
3Y
5Y
10Y
15Y
GLSI
21.11.2021 - 28.11.2021

Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. Greenwich LifeSciences, Inc. was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. The company was incorporated in 2006 and is headquartered in Stafford, Texas. Address: Building 14, Stafford, TX, United States, 77477

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

39.00 USD

P/E ratio

Dividend Yield

Financials GLSI

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures GLSI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

+3 612 USD

Last Quarter

Current Year

Last Year

-3 612 USD

Current Quarter

+1 806 USD

Last Quarter

EBITDA -16 753 336 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -253.55 %
PEG Ratio
Return On Equity TTM -515.27 %
Wall Street Target Price 39.00 USD
Revenue TTM
Book Value 0.099 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.27 USD
Diluted Eps TTM -1.27 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation GLSI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -21.23
Price Book MRQ 90.87

Technical indicators GLSI

For 52 weeks

8.06 USD 18.15 USD
50 Day MA 9.62 USD
Shares Short Prior Month 1 008 267
200 Day MA 12.07 USD
Short Ratio 26.16
Shares Short 959 858
Short Percent 15.03 %